ROCK specific inhibitor fasudil suppresses head and neck squamous carcinoma growth by stimulating gene expression and protein secretion of the chemokine CXCL14/BRAK

被引：0
|
作者：
Miyamoto, C. [1 ]
Ozawa, S. [1 ]
Ikoma, T. [1 ]
Wada-Takahashi, S. [1 ]
Takahashi, S. -S. [1 ]
Yoshida, A. [1 ]
Yoshino, F. [1 ]
Hata, R. -I. [1 ]
Lee, M. C. -I. [1 ]
Maehata, Y. [1 ]
机构：
[1] Kanagawa Dent Univ, Kanagawa, Japan
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
Cancer related proteins; Cancer signaling; CXCL14/BRAK;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TUE-209
引用
收藏
页码：501 / 501
页数：1
相关论文
共 16 条
  • [1] Fasudil Suppresses Fibrosarcoma Growth by Stimulating Secretion of the Chemokine CXCL14/BRAK
    Miyamoto, Chihiro
    Maehata, Yojiro
    Ozawa, Shigeyuki
    Ikoma, Takeharu
    Kubota, Eiro
    Izukuri, Kazuhito
    Kato, Yasumasa
    Hata, Ryu-Ichiro
    Lee, Masaichi-Chang-il
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 120 (03) : 241 - 249
  • [2] Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma
    Miyamoto, Chihiro
    Maehata, Yojiro
    Motohashi, Kazuhiko
    Ozawa, Shigeyuki
    Ikoma, Takeharu
    Hidaka, Kouki
    Wada-Takahashi, Satoko
    Takahashi, Shun-Suke
    Yoshino, Fumihiko
    Yoshida, Ayaka
    Kubota, Eiro
    Hata, Ryu-Ichiro
    Lee, Masaichi-Chang-il
    BIOMEDICAL RESEARCH-TOKYO, 2014, 35 (06): : 381 - 388
  • [3] Expression of BRAK/CXCL14 is associated with antitumor efficacy of gefitinib in head and neck squamous cell carcinoma
    Hata, R.
    Ozawa, S.
    Kato, Y.
    Ito, S.
    Komori, R.
    Shiiki, N.
    Tsukinoki, K.
    Maehata, Y.
    Kubota, E.
    EJC SUPPLEMENTS, 2009, 7 (02): : 477 - 478
  • [4] Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma
    Ozawa, Shigeyuki
    Kato, Yasumasa
    Ito, Shin
    Komori, Reika
    Shiiki, Naoto
    Tsukinoki, Keiichi
    Ozono, Satoru
    Maehata, Yojiro
    Taguchi, Takahide
    Imagawa-Ishiguro, Yukari
    Tsukuda, Mamoru
    Kubota, Eiro
    Hata, Ryu-Ichiro
    CANCER SCIENCE, 2009, 100 (11): : 2202 - 2209
  • [5] BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells
    Ozawa, Shigeyuki
    Kato, Yasumasa
    Komori, Reika
    Maehata, Yojiro
    Kubota, Eiro
    Hata, Ryu-Ichiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 348 (02) : 406 - 412
  • [6] Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells
    Maehata, Yojiro
    Ozawa, Shigeyuki
    Kobayashi, Kyo
    Kato, Yasumasa
    Yoshino, Fumihiko
    Miyamoto, Chihiro
    Izukuri, Kazuhito
    Kubota, Eiro
    Hata, Ryu-Ichiro
    Lee, Masaichi-Chang-Il
    FREE RADICAL RESEARCH, 2010, 44 (08) : 913 - 924
  • [7] Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma
    Kondo, T.
    Ozawa, S.
    Ikoma, T.
    Yang, X-Y
    Kanamori, K.
    Suzuki, K.
    Iwabuchi, H.
    Maehata, Y.
    Miyamoto, C.
    Taguchi, T.
    Kiyono, T.
    Kubota, E.
    Hata, R-I
    ONCOGENESIS, 2016, 5 : e240 - e240
  • [8] Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma
    T Kondo
    S Ozawa
    T Ikoma
    X-Y Yang
    K Kanamori
    K Suzuki
    H Iwabuchi
    Y Maehata
    C Miyamoto
    T Taguchi
    T Kiyono
    E Kubota
    R-I Hata
    Oncogenesis, 2016, 5 : e240 - e240
  • [9] Reactive oxygen species reduce the production of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells
    Miyamoto, Chihiro
    Maehata, Yojiro
    Yoshino, Fumihiko
    Kobayashi, Kyo
    Lee, Masaichi-Chang-il
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 : S173 - S173
  • [10] Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo
    Ito, Shin
    Ozawa, Shigeyuki
    Ikoma, Takeharu
    Yajima, Nobuyuki
    Kiyono, Tohru
    Hata, Ryu-Ichiro
    BIOMEDICAL RESEARCH-TOKYO, 2010, 31 (03): : 199 - 206
12